What are Diabetes Canada's recommendations for postpartum screening and management in women with a history of Gestational Diabetes Mellitus (GDM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diabetes Canada's Recommendations for Postpartum Screening in Women with GDM

Women with a history of gestational diabetes mellitus (GDM) should be screened at 4-12 weeks postpartum using a 75-g oral glucose tolerance test (OGTT) with non-pregnancy diagnostic criteria, followed by lifelong screening for diabetes every 1-3 years. 1, 2

Postpartum Screening Protocol

Initial Postpartum Testing (4-12 weeks)

  • A 75-g OGTT is the recommended screening test at 4-12 weeks postpartum 1, 2
  • HbA1c is not recommended for initial postpartum screening because:
    • Values may be persistently impacted by increased red blood cell turnover during pregnancy
    • Blood loss at delivery can affect results
    • The preceding 3-month glucose profile may not be representative 1
  • Diagnostic criteria for the 75-g OGTT (using non-pregnancy criteria):
    • Diabetes: Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) or 2-h plasma glucose ≥200 mg/dL (11.1 mmol/L)
    • If only one abnormal value meets diabetes criteria, the test should be repeated to confirm 1

Long-term Follow-up

  • Lifelong screening for diabetes development every 1-3 years 1, 2
  • Any recommended glycemic test can be used for ongoing evaluation:
    • Annual HbA1c
    • Annual fasting plasma glucose
    • Triennial 75-g OGTT 1

Rationale for Screening

  • GDM often represents previously undiagnosed prediabetes, type 2 diabetes, or developing type 1 diabetes 1
  • Women with GDM have a 50-60% lifetime risk of developing type 2 diabetes 1, 2
  • Risk of progression to diabetes increases linearly over time 1, 2

Management Recommendations for Women with Prediabetes

  • Intensive lifestyle interventions and/or metformin should be offered to women with overweight/obesity and history of GDM who develop prediabetes 1, 2
  • The Diabetes Prevention Program found that progression to diabetes can be delayed or prevented by intervention 1
  • In the Nurses' Health Study II, diabetes risk after GDM was significantly lower in women who followed healthy eating patterns 1

Additional Postpartum Recommendations

  • Breastfeeding is recommended to reduce the risk of maternal type 2 diabetes 1, 2
  • A contraceptive plan should be discussed and implemented 1
  • Preconception screening for diabetes should be sought before future pregnancies 1, 2
  • Postpartum care should include psychosocial assessment and support for self-care 1, 2

Common Pitfalls in Postpartum GDM Management

  1. Poor screening completion rates: Only about 40-53% of women complete the recommended 6-12 week postpartum OGTT 3, 4. Team-based approaches to care can improve screening rates from 39% to 77% 3.

  2. Relying on HbA1c alone for initial postpartum screening: HbA1c may be falsely lowered due to pregnancy-related changes in red blood cell turnover and postpartum blood loss 1.

  3. Failure to provide long-term follow-up: Many women are lost to follow-up after the initial postpartum period, despite their high lifetime risk of developing type 2 diabetes 1.

  4. Missing opportunities for diabetes prevention: Women with prediabetes after GDM benefit significantly from lifestyle interventions and/or metformin, but these interventions are often not implemented 1, 2.

By following these evidence-based recommendations for postpartum screening and management, healthcare providers can significantly reduce the risk of type 2 diabetes development in women with a history of GDM.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gestational Diabetes Mellitus Screening and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.